Internal Medicine, Gastroenterology · Englewood, NJ
NPI
1619929874
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
420 Grand Ave, Suite 101
Englewood, NJ, 07631
Phone (201) 569-7044
Groups this clinician bills Medicare through
Medicare paid, 2024
$243K
18,383 services
Medicare patients, 2024
627
Average age 76
Drug cost, 2024
$662K
2,108 prescriptions
Company payments, 2025
$1,724
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark S Sapienza was code J1439 (injection, ferric carboxymaltose, 1 mg), 11,250 times for 11 patients. In total Mark S Sapienza billed 18,383 services in 61 codes, and Medicare paid $243K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 11,250 | 11 | $0.76 | $8,575 |
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 4,800 | 11 | $17.47 | $84K |
| 99214 Office E&M - Established | Office | 380 | 250 | $98.80 | $38K |
| 99232 Hospital E&M - Subsequent | Facility | 181 | 81 | $67.05 | $12K |
| 43239 Upper GI Endoscopy | Facility | 114 | 113 | $91.54 | $10K |
| 99213 Office E&M - Established | Office | 90 | 81 | $71.76 | $6,458 |
| 45385 Colonoscopy - Lesion Removal | Facility | 89 | 89 | $223.99 | $20K |
| 99222 Hospital E&M - Initial | Facility | 62 | 62 | $108.74 | $6,742 |
| 99204 Office E&M - New | Office | 49 | 49 | $118.36 | $5,800 |
| 45380 Lower GI Endoscopy - Other | Facility | 45 | 45 | $139.21 | $6,265 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 33 | 33 | $196.47 | $6,484 |
| 99203 Office E&M - New | Office | 31 | 31 | $82.01 | $2,542 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 28 | 28 | $196.03 | $5,489 |
| 96365 Intravenous Infusion, Hydration | Office | 22 | 17 | $51.98 | $1,144 |
| 96413 Chemotherapy Administration | Office | 22 | 15 | $108.23 | $2,381 |
By year: 2022 $155K for 2,954 services; 2023 $194K for 4,288 services; 2024 $243K for 18,383 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark S Sapienza prescribed most often to Medicare patients was Pantoprazole Sodium, with 247 prescriptions and refills. In total Mark S Sapienza wrote 2,108 Medicare prescriptions that cost $662K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 247 | 667 | 75 | $4,658 |
| Omeprazole Generic | 146 | 383 | 46 | $2,495 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 144 | 144 | 142 | $8,786 |
| Esomeprazole Magnesium Generic | 117 | 289 | 35 | $4,749 |
| Famotidine Generic | 76 | 208 | 29 | $1,223 |
| Atorvastatin Calcium Generic | 75 | 187 | 20 | $861 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 58 | 58 | 56 | $717 |
| Amlodipine Besylate Generic | 56 | 164 | 17 | $515 |
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 48 | 48 | 47 | $1,011 |
| Escitalopram Oxalate Generic | 45 | 85 | Under 11 | $500 |
| Losartan Potassium Generic | 43 | 101 | Under 11 | $327 |
| Mesalamine Generic | 41 | 97 | Under 11 | $21K |
| Dicyclomine Hcl Generic | 40 | 54 | 13 | $560 |
| Simvastatin Generic | 38 | 114 | 11 | $560 |
| Levothyroxine Sodium Generic | 38 | 91 | Under 11 | $455 |
Brand drugs: 293 claims; generic drugs: 1,815 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark S Sapienza $1,724 ($1,724 in general payments such as food, travel and fees) from 17 companies. The largest payer was Janssen Biotech, Inc. with $481.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 16 | $481 |
| Abbvie Inc. ABBV | 18 | $298 |
| Madrigal Pharmaceuticals MDGL | 12 | $257 |
| Janssen Scientific Affairs, LLC JNJ | 3 | $237 |
| Celltrion USA Inc. 068270.KS | 6 | $105 |
| Aimmune Therapeutics, Inc. | 3 | $52.68 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $45.17 |
| Intercept Pharmaceuticals, Inc. | 2 | $43.53 |
| Ardelyx, Inc. ARDX | 2 | $35.52 |
| Novo Nordisk Inc NVO | 2 | $34.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.